Oruka Therapeutics (ORKA) total assets

Total assets · fiscal 2025
$488.62M

Oruka Therapeutics (ORKA) had total assets of $488.62M at the end of fiscal 2025 (December 31, 2025). That is 23.4% higher than the $396.02M of fiscal 2024. Figures as of 18 Nov 2026, 04:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$488.62M
Change on fiscal 2024
+23.4%
Growth, 5 years
+57.5% a year
Growth, 10 years
+28.6% a year
Highest on record
$488.62Mfiscal 2025
Lowest on record
$3.21Mfiscal 2012
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Oruka Therapeutics total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 57.5% a year; over ten years the rate was 28.6% a year. Across the 16 fiscal years on record (2010–2025), the highest was $488.62M in fiscal 2025 and the lowest $3.21M in fiscal 2012.

History · 16 fiscal years

Total assets by fiscal year

Oruka Therapeutics total assets, year by year

Oruka Therapeutics (ORKA) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$488.62M 23.4% up
2024$396.02M 946.0% up
2023$37.86M 12.1% down
2022$43.09M 21.6% down
2021$54.92M 8.9% up
2020$50.43M 490.8% up
2019$8.54M 25.1% up
2018$6.83M 44.8% down
2017$12.37M 49.8% down
2016$24.63M 37.8% down
2015$39.57M 145.3% up
2014$16.13M 5.6% down
2013$17.08M 431.9% up
2012$3.21M 50.6% down
2011$6.50M 20.3% down
2010$8.16M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Oruka Therapeutics and comparable companies
CompanyTotal assetsFiscal year
Immunovant IMVT$957.01M2026
Axsome Therapeutics AXSM$689.81M2025
Chemed CHE$1.54B2025
Oruka Therapeutics ORKA$488.62M2025
Arrowhead Pharmaceuticals ARWR$1.74B2026
MSA Safety MSA$2.55B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ORKA

Oruka Therapeutics, figure by figure

Oruka Therapeutics (ORKA) overview: price, valuation and scorecardAll health care companies by market value

Oruka Therapeutics total assets: questions and answers

How large are Oruka Therapeutics's total assets?

Oruka Therapeutics (ORKA) had total assets of $488.62M at the end of fiscal 2025 (December 31, 2025). That is 23.4% higher than the $396.02M of fiscal 2024.

What is the growth rate of Oruka Therapeutics's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 57.5% a year; over ten years the rate was 28.6% a year.

What are the highest and lowest total assets figures on record for Oruka Therapeutics?

Across the 16 fiscal years on record (2010–2025), the highest was $488.62M in fiscal 2025 and the lowest $3.21M in fiscal 2012.

How is Oruka Therapeutics's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Oruka Therapeutics (ORKA) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/ORKA/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.